A dose- and time-dependent induction of autophagy observed in tumor cells following cisplatin treatment is evidenced by up-regulation Beclin-1 and cisplatin-triggered activation of AMPK pathway leading to a subsequent suppression of mTOR activity [28]. Here, BECN1 is linked to neoplasm.